These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 19718628)
1. Use of an immune functional assay to differentiate recurrent hepatitis C from acute cellular rejection in liver transplant patients. Rubinas T; Dellon E; Henel G Liver Transpl; 2009 Sep; 15(9):1157. PubMed ID: 19718628 [No Abstract] [Full Text] [Related]
2. Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post-liver transplant biopsies. Jain A; Ryan C; Mohanka R; Orloff M; Abt P; Romano J; Bryan L; Batzold P; Mantry P; Bozorgzadeh A Clin Transplant; 2006; 20(5):624-33. PubMed ID: 16968489 [TBL] [Abstract][Full Text] [Related]
3. Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patients. Cabrera R; Ararat M; Soldevila-Pico C; Dixon L; Pan JJ; Firpi R; Machicao V; Levy C; Nelson D; Morelli G Liver Transpl; 2009 Feb; 15(2):216-22. PubMed ID: 19177434 [TBL] [Abstract][Full Text] [Related]
4. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation. de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408 [TBL] [Abstract][Full Text] [Related]
5. C4d in acute rejection after liver transplantation and its usefulness in differential diagnosis between acute liver rejection and hepatitis C recurrence. Gierej B; Kobryń K; Gierej P; Górnicka B Ann Transplant; 2014 Aug; 19():373-81. PubMed ID: 25082343 [TBL] [Abstract][Full Text] [Related]
6. The interrelation between recurrent hepatitis C, alloimmune response, and immunosuppression. Shaked A Liver Transpl; 2005 Nov; 11(11):1329-31. PubMed ID: 16237699 [No Abstract] [Full Text] [Related]
7. Recurrent hepatitis C and acute allograft rejection: clinicopathologic features with emphasis on the differential diagnosis between these entities. Moreira RK Adv Anat Pathol; 2011 Sep; 18(5):393-405. PubMed ID: 21841407 [TBL] [Abstract][Full Text] [Related]
8. Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients. Selzner N; Guindi M; Renner EL; Berenguer M J Hepatol; 2011 Jul; 55(1):207-17. PubMed ID: 21145865 [TBL] [Abstract][Full Text] [Related]
9. Reply: Prospective validation of a noninvasive index for predicting liver fibrosis in hepatitis C virus-infected liver transplant recipients. Cross TJ; Burroughs AK; Harrison PM Liver Transpl; 2010 Jun; 16(6):789-90; author reply 791-2. PubMed ID: 20517916 [No Abstract] [Full Text] [Related]
10. c-Kit-positive mast cells in portal tracts cannot be used to distinguish acute cellular rejection from recurrent hepatitis C infection in liver allografts. Doria C; di Francesco F; Marino IR; Ramirez CB; Frank A; Iaria M; Galati SA; Farber JL Transplant Proc; 2006 Dec; 38(10):3597-600. PubMed ID: 17175342 [TBL] [Abstract][Full Text] [Related]
11. Liver transplant complications in hepatitis C infected recipients: recurrence versus rejection. Gehrau RC; Mas VR; Suh JL; Maluf DG Expert Rev Gastroenterol Hepatol; 2014 Jul; 8(5):453-6. PubMed ID: 24641719 [TBL] [Abstract][Full Text] [Related]
12. Fatal impact of lymphocyte cross-matching upon humoral rejection after adult living related liver transplantation. Hori T; Egawa H; Takada Y; Oike F; Ogura Y; Ogawa K; Kaido T; Toshimitsu Y; Yagi S; Iida T; Nguyen JH; Uemoto S Transpl Int; 2010 Mar; 23(3):338-40. PubMed ID: 19725911 [No Abstract] [Full Text] [Related]
13. Noninvasive tests in the post-liver transplantation setting. Cholongitas E; Senzolo M; Quaglia A; Patch D; Dhillon AP; Burroughs AK Liver Transpl; 2007 Apr; 13(4):626-7; author reply 628-9. PubMed ID: 17394169 [No Abstract] [Full Text] [Related]
14. The natural history of hepatitis C cirrhosis after liver transplantation. Firpi RJ; Clark V; Soldevila-Pico C; Morelli G; Cabrera R; Levy C; Machicao VI; Chaoru C; Nelson DR Liver Transpl; 2009 Sep; 15(9):1063-71. PubMed ID: 19718647 [TBL] [Abstract][Full Text] [Related]
15. Change in composition of inflammatory infiltrate in the course of hepatitis C reinfection and concomitant acute rejection after orthotopic liver transplantation. Ziarkiewicz-Wróblewska B; Wróblewski T; Ciszek M; Kalinowski P; Malejczyk J Ann Transplant; 2014 Jan; 19():41-50. PubMed ID: 24457607 [TBL] [Abstract][Full Text] [Related]
16. Mission poorly accomplished: the protective role of natural killer cells in recurrent hepatitis C after liver transplantation. Zein NN Liver Transpl; 2008 Jan; 14(1):4-6. PubMed ID: 18161796 [No Abstract] [Full Text] [Related]
17. Hepatic parenchymal changes and histologic eosinophilia as predictors of subsequent acute liver allograft rejection. Demirhan B; Bilezikçi B; Haberal AN; Sevmiş S; Arat Z; Haberal M Liver Transpl; 2008 Feb; 14(2):214-9. PubMed ID: 18236397 [TBL] [Abstract][Full Text] [Related]
18. The common I148 M variant of PNPLA3 does not predict fibrosis progression after liver transplantation for hepatitis C. do O NT; Eurich D; Trautwein C; Neuhaus P; Neumann UP; Wasmuth HE Hepatology; 2011 Oct; 54(4):1483-4. PubMed ID: 21748761 [No Abstract] [Full Text] [Related]
19. Natural killer cells play divergent roles in shaping the outcome of hepatitis C virus recurrence following liver transplantation. Golden-Mason L Liver Transpl; 2009 Apr; 15(4):357-9. PubMed ID: 19326413 [No Abstract] [Full Text] [Related]
20. [Hepatitis C recurrence after liver transplantation]. Guo F; Wei L Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):382-4. PubMed ID: 15225448 [No Abstract] [Full Text] [Related] [Next] [New Search]